Immunosuppressive peptides and their therapeutic applications. - Test2 - elhamkhani - TriplyDB

Immunosuppressive peptides and their therapeutic applications.

Immunosuppressive peptides and their therapeutic applications.

http://www.wikidata.org/entity/Q38170857

about

Effects of chalcone derivatives on players of the immune system Novel formulations for antimicrobial peptides Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum.Peptidomics of Circular Cysteine-Rich Plant Peptides: Analysis of the Diversity of Cyclotides from Viola tricolor by Transcriptome and Proteome Mining Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.Discovery, structure, function, and applications of cyclotides: circular proteins from plants.Identification of Cyclic Depsipeptides and Their Dedicated Synthetase from Hapsidospora irregularis.Modulation of Human Immune Response by Fungal Biocontrol Agents.Cyclotides: Overview and Biotechnological Applications.From ethnopharmacology to drug design.Chemical Proteomics for Target Discovery of Head-to-Tail Cyclized Mini-Proteins.Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.Ascidian Toxins with Potential for Drug Development.

P2860

Q26796454-EC75A78D-798C-498B-8591-DDCE3FC2C9A8 Q26991771-6FC0BF3F-F304-4E68-AEAD-858EFA623754 Q35610164-B5C4316F-4A3E-4AA0-BC26-CBAF695935F9 Q35785634-33CFEE93-CCC9-4F1F-B7EE-7805ACE00C6A Q36821577-91CAF8AA-B54C-4446-9EB9-844E3551C561 Q38843873-39FE1B8F-C6BD-4877-AD24-DF894CD5955D Q39010136-3433D5EC-CA20-45E9-9E06-9A990407D9CE Q39143535-83B6800E-7853-4F6B-9BE9-B6274D90E3EE Q39330201-CAE66DEA-EEE4-4443-AD21-B86663F83725 Q41957546-E31D1128-835D-4C53-A55E-5B6F317159A2 Q42654389-CCF91425-2CCA-4054-8D8B-271C055AEF4A Q46003077-D1F26803-A929-41C3-A2BC-AC525B869EA1 Q54988462-9BD4659D-6BF6-4227-AFAF-FBF261D6136B

P2860

Immunosuppressive peptides and their therapeutic applications.

http://www.wikidata.org/entity/Q38170857

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immunosuppressive peptides and their therapeutic applications.

@en

type

label

Immunosuppressive peptides and their therapeutic applications.

@en

prefLabel

Immunosuppressive peptides and their therapeutic applications.

@en

P1433

Q38170857-2132D705-D57F-41D6-BC94-ABF9D9AE469D

P1476

Q38170857-9510CC12-4E12-4506-99B4-D2751FB98C23

P2093

Q38170857-CE755DFD-85CF-46A3-A1FD-41EF98F1D89C

P275

Q38170857-375D98C1-0BA0-44AE-87B8-7C032C968DA2

P2860

Q38170857-030E66E9-A125-45C5-81F5-7DA1D752B8CF

Q38170857-035D902D-D0CB-4040-9469-103102376C80

Q38170857-05C45D04-9B17-4C82-8F2E-FD865958F147

Q38170857-06371292-A73C-4A72-BED3-4C73CF8150D0

Q38170857-0696962F-6231-4FCF-BD17-8E462CCDBEBE

Q38170857-08280004-C415-41C3-8ADC-72CF204953F7

Q38170857-09E463FC-1C8B-4F84-A1B8-05F36D058DB2

Q38170857-0CE242DA-8397-4EB6-9E7D-04C537D5A477

Q38170857-18157559-AC66-4826-872B-282DEA9BB224

Q38170857-188BC17B-FAE3-415F-80DD-49849DC6D13A

P304

Q38170857-98A7760B-358D-4C8F-B354-FC2FA42D48C2

P31

Q38170857-BB803F8E-4A81-48AE-AAF9-6657226E4972

P356

Q38170857-6CC39476-D7F4-469A-814E-D342491B625A

P433

Q38170857-894C4317-60C9-45A7-B162-87BDE55D3B72

P478

Q38170857-10AEB156-4EB9-4511-819D-AA987439BC59

P50

Q38170857-71F88F62-3D4B-473B-AE72-386430C3DC10

Q38170857-9AEB9C61-3B08-4FCB-9D7F-90CA3F528070

Q38170857-B453C135-638A-4F95-88D0-7B1AFC46DC26

P577

Q38170857-C57AA59F-F1D3-4AE3-B927-B9E49584BCD5

P5875

Q38170857-673C03F1-231D-4CC9-B5A9-B5D7AE1098C1

P698

Q38170857-7ABB104D-3463-45AE-8FCB-C09B6A6D034C

P921

Q38170857-88E9014F-6797-414B-B31F-6FAD37159F94

P932

Q38170857-A7611CCE-9D5E-4CE4-9DBD-FF251F489A65

P356

J.DRUDIS.2013.12.002

P1433

Drug Discovery Today

P1476

Immunosuppressive peptides and their therapeutic applications

@en

P2093

Kathrin Thell

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore

Signaling by target of rapamycin proteins in cell growth control

A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3

Ion channels and transporters in lymphocyte function and immunity

Scorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineering

Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature

The conserved glu in the cyclotide cycloviolacin O2 has a key structural role

mTOR kinase structure, mechanism and regulation

Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes

In Vivo Activation of the p53 Tumor Suppressor Pathway by an Engineered Cyclotide

P304

645-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUDIS.2013.12.002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Christian Gruber

Roland Hellinger

Gernot Schabbauer

P577

2013-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259318235

http://www.w3.org/2001/XMLSchema#string

P698

24333193

http://www.w3.org/2001/XMLSchema#string

P921

P932

4042018

http://www.w3.org/2001/XMLSchema#string